Spoken Alpha
TriSalus Life Sciences, Inc.
TriSalus Life Sciences designs and manufactures medical devices and develops immunotherapies for treating solid tumors. The company's TriNav infusion system uses pressure-enabled drug delivery technology to improve therapeutic delivery to liver and pancreatic tumors during minimally invasive procedures like radioembolization and chemoembolization.
TriSalus Life Sciences, Inc.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add TLSIW, reply to your welcome email and we'll prioritize it.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for TLSIW.
$ curl https://api.spokenalpha.com/v1/companies/TLSIWFAQ
Spoken Alpha indexes TLSIW's earnings call transcripts at https://spokenalpha.com/companies/TLSIW. Each call links to attributed speakers and parsed analyst Q&A. TriSalus Life Sciences, Inc.'s own investor relations page is at https://trisaluslifesciences.com/investors.